Literature DB >> 26270206

Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice?

Rodolfo Sacco1, Michela Antonucci2, Irene Bargellini3, Sara Marceglia4, Valeria Mismas1, Giuseppe Cabibbo5.   

Abstract

Entities:  

Keywords:  HCC; TACE; combination therapy; intermediate stage; sorafenib

Mesh:

Substances:

Year:  2015        PMID: 26270206     DOI: 10.2217/FON.15.173

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  5 in total

Review 1.  Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review.

Authors:  Rodolfo Sacco; Gherardo Tapete; Natalia Simonetti; Rossella Sellitri; Veronica Natali; Sara Melissari; Giuseppe Cabibbo; Lilia Biscaglia; Giampaolo Bresci; Luca Giacomelli
Journal:  J Hepatocell Carcinoma       Date:  2017-07-27

Review 2.  Chemoembolization With Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma.

Authors:  Kathy Diener Dasse; Michael J Lander; Paula M Novelli
Journal:  J Adv Pract Oncol       Date:  2016-11-01

3.  Comparison between Y90 Radioembolization Plus Sorafenib and Y90 Radioembolization alone in the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis.

Authors:  Antonio Facciorusso; Irene Bargellini; Marina Cela; Ivan Cincione; Rodolfo Sacco
Journal:  Cancers (Basel)       Date:  2020-04-07       Impact factor: 6.639

4.  Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma.

Authors:  Armeen Mahvash; Ravi Murthy; Bruno C Odisio; Kanwal Pratap Raghav; Lauren Girard; Sheree Cheung; Van Nguyen; Joe Ensor; Sameer Gadani; Khaled M Elsayes; Reham Abdel-Wahab; Manal Hassan; Ahmed S Shalaby; James C Yao; Michael J Wallace; Ahmed O Kaseb
Journal:  J Hepatocell Carcinoma       Date:  2016-02-05

5.  Comparison between Child-Pugh Score and albumin-bilirubin grade in patients treated with the combination therapy of transarterial chemoembolization and sorafenib for hepatocellular carcinoma.

Authors:  Zhexuan Wang; Qingling Fan; Mengmeng Wang; Enxin Wang; Huichen Li; Lei Liu
Journal:  Ann Transl Med       Date:  2020-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.